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Abstract
Background: Transcriptional enhancers are frequently bound by a set of transcription factors that collaborate to
activate lineage-specific gene expression. Recently, it was appreciated that a subset of enhancers comprise
extended clusters dubbed stretch- or super-enhancers (SEs). These SEs are located near key cell identity genes, and
enriched for non-coding genetic variations associated with disease. Previously, SEs have been defined as having the
highest density of Med1, Brd4 or H3K27ac by ChIP-seq. The histone acetyltransferase P300 has been used as a
marker of enhancers, but little is known about its binding to SEs.
Results: We establish that P300 marks a similar SE repertoire in embryonic stem cells as previously reported using
Med1 and H3K27ac. We also exemplify a role for SEs in mouse T helper cell fate decision. Similarly, upon activation
of macrophages by bacterial endotoxin, we found that many SE-associated genes encode inflammatory proteins
that are strongly up-regulated. These SEs arise from small, low-density enhancers in unstimulated macrophages. We
also identified expression quantitative trait loci (eQTL) in human monocytes that lie within such SEs. In
macrophages and Th17 cells, inflammatory SEs can be perturbed either genetically or pharmacologically thus
revealing new avenues to target inflammation.
Conclusions: Our findings support the notion that P300-marked SEs can help identify key nodes of transcriptional
control during cell fate decisions. The SE landscape changes drastically during cell differentiation and cell activation.
As these processes are crucial in immune responses, SEs may be useful in revealing novel targets for treating
inflammatory diseases.
Keywords: Transcriptional regulation, Lysine acetylation, Epigenetics, Long non-coding RNA, Systems biology,
Inflammation, Cell differentiation, Super-enhancers
Background
Recently, clusters of enhancers termed stretch- or
super-enhancers (SEs) were identified as large cis-acting
elements in the genome that uniquely regulate cell
lineage-specific gene transcription and define cell iden-
tity [1, 2]. SEs are characterized by potent transcriptional
enhancer activity that correlates with high occupancy by
transcription factors (TFs) and co-activators, and pro-
nounced sensitivity to perturbation [3]. Additionally, non-
coding disease-associated genetic variation is enriched in
SEs [2, 4]. To identify SEs, the binding density of Med1, a
subunit of the transcriptional Mediator protein complex,
was originally used [1, 3]. Similarly, Brd4, a member of the
bromodomain and extraterminal (BET) family of tran-
scriptional coactivators that interact with Mediator, can
also be used to identify SEs [3].
Since SEs are central to cell identity, they may help
find factors for direct reprogramming of cells, or identify
drug targets to treat diseases. We explore this latter no-
tion by analyzing P300 density at enhancer sites in cell
transition states. Pioneering studies have demonstrated
that chromatin immuno-precipitation followed by deep
sequencing (ChIP-seq) can reliably measure binding of
P300, a histone acetyltransferase and transcription acti-
vator, across the genome to predictively map transcrip-
tional enhancer elements active in vivo [5–7].
Although SEs have been shown to regulate cell identity
genes in resting steady state, the role of SEs in regulating
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transition states such as cell differentiation and activa-
tion is not well appreciated. Several epiblast stem cell
SEs have been reported to arise from ‘seed’ enhancers in
embryonic stem cells [8, 9], however this observation
has not been analyzed systematically in other cell types.
Since these transition states are frequently targeted in
therapies for inflammatory disease and cancer, we char-
acterized the dynamic regulation of enhanceosome as-
sembly using the well known transcriptional co-activator
protein P300. First, we establish P300 as a reliable mark
of SEs, then show that high-density P300 SEs are in-
duced in cell transition states and are located near cell
identity and disease susceptibility genes.
We also find that non-coding transcription is often asso-
ciated with SEs. Long non-coding RNAs (lncRNAs), which
associate with chromatin modifying complexes and play
roles in gene expression regulation either in cis or trans
[10, 11], are much more likely to be located in proximity
to SEs than conventional enhancers (CEs). LncRNAs are
RNA transcripts greater than 200 base pairs in length, and
are often spliced and polyadenylated. A category of non-
coding RNAs arising from enhancer regions, known as en-
hancer RNAs (eRNAs), participate in enhancer activity
and regulate neighboring genes [12]. These eRNA tran-
scripts often lack polyadenylation, as well as the typical
H3K4me3 promoter signature present in the loci for other
classes of lncRNA genes [11, 13, 14]. Here, we show that
some eRNAs are coincident with some SE regions.
Finally, we found that the TLR4 stimulated inflamma-
tory response led to drastic remodeling of SEs in macro-
phages. Many SE-associated genes are highly induced,
suggesting that inflammation can be targeted by block-
ing SEs. Small molecule BET inhibitors effectively dis-
able SEs in tumor cell lines and stop cell growth [3],
and we show that chemical inhibitors that abrogate SE
function also block expression of inflammatory genes,
as well as affect cell fate decisions in macrophages and
T helper cells.
Results
Characterization of P300-marked super-enhancers
P300, also known as E1A-binding protein, 300 kD
(EP300), has been previously used to identify enhancers
[5–7], and it was recently suggested that P300 may also
mark SEs [4, 15]. To determine whether P300 can be
used to identify SEs, we analyzed P300, Med1, and
H3K27ac ChIP-seq data in mouse embryonic stem cells
(mESCs). We found that P300 is especially dense at pre-
viously reported SE sites, including the important pluri-
potency genes Pou5f1 and Sox2 (Fig. 1b, Additional file
1: Figure S1d). When enhancers were ranked by density,
P300 had a similar distribution plot to Med1 and
H3K27ac, recovering 88 % (221/250) of Med1 SEs
(Fig. 1a). There is a high correlation of P300 and Med1
at these shared sites (Additional file 1: Figure S1A). The
non-coding Pvt1 gene neighboring Myc that harbors a
SE was recently shown to contribute to high expression
of this locus in cancer cells [16]. A P300-marked SE
overlaps this locus, and may contribute to its expression
in mESCs (Fig. 1b, upper panel). Genes near SEs are
highly expressed in mESCs relative to genes associated
with conventional enhancers (CEs) (p-value ≤ 2e-11, Stu-
dents t-test) and all expressed genes on average (p-value ≤
3e-13, Students t-test) (Fig. 1c). We also observed that SEs
are closer to transcription start sites than CEs are, on aver-
age, and it is possible that this property is related to the in-
creased gene expression associated with SEs (Additional
file 2: Table S1B). Furthermore, SEs are large on average,
as expected (Additional file 1: Figure S1C). In the exam-
ples that we show, the P300 SEs are co-bound by Oct4,
Nanog, and Sox2 (Fig. 1b, d, e and Additional file 1: Figure
S1D), which has been reported to be a feature of SEs in
general in mESCs [17].
P300 SEs participate in long-range chromatin interac-
tions by looping to promoters (Additional file 1: Figure
S1E), a known mechanism of action for transcriptional en-
hancers and SEs [18]. For example, we show such an inter-
action between the promoter of a stem cell self-renewal
gene L1td1 [19] and a SE 110 kb 3' (Fig. 1d, upper panel),
detected from RNA-polymerase II ChIA-PET data [20].
The gene Kank4 is located in between the SE and L1td1
but appears to be completely bypassed and accordingly is
not expressed in mESCs. As another example, we detect
chromatin interaction between the promoter of Epha2
and a SE 15 kb 5' (Fig. 1d, lower panel). Finally, we found
that P300 was able to detect one putative SE that was not
detected by Med1 in mESCs (Fig. 1e) [21]. It is possible
that other SEs may not have been detected by Med1, how-
ever this remains to be determined. This suggests that
P300 may assist in identifying additional SEs that are im-
portant biological targets not found in previous analysis
using Med1 alone. Binding of P300, Med1, and H3K27ac
is present in this SE, suggesting that SEs are marked by all
three factors; however, they do not necessarily have
enough factor density to make the SE cutoff for all three
factors. A closely related paralog to P300, CBP, has also
been used to mark SEs [4, 22], and we show that it can
identify a highly similar SE repertoire as P300, suggesting
that these two factors have similar associations with SEs
(Additional file 1: Figure S1F).
Since P300 ChIP-seq appears to be a robust method
for systematic identification of SEs, we analyzed all avail-
able P300 ChIP-seq data sets from multiple cells and tis-
sues, in both human and mouse, and integrated the
results with previously reported SEs, increasing the total
number of SE datasets to >200 (Additional file 2: Table
S1). Datasets for the P300 paralog CBP are included as
well [4, 22]. These catalogs can be explored via our
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Fig. 1 Identification of P300 dense super-enhancers. a Ranked distribution plot of P300, Med1, or H3K27ac binding density identifies a small
subset of SEs (above the inflection point) in mouse ESCs. Venn diagram (inset) shows the overlap between P300, Med1, and H3K27ac marked SEs.
ChIP-seq data are from [71, 72]. b Genome browser screenshot depicting mESC RNA-seq and ChIP-seq data as labeled. (Top panel) The Myc gene
is adjacent to Pvt1, a lncRNA overlapping with a SE identified by P300, Med1 and H3K27ac. (Bottom panel) Oct4 is encoded by the Pou5f1 locus
which harbors a SE marked by P300, Med1, and H3K27ac. In addition, P300 co-localizes with the core pluripotency factors Oct4, Sox2, and Nanog
in both cases. c Expression of genes near P300 SEs and CEs. Genes that are located within 100 kb of a SE are expressed at higher levels than
those near a CE, and all expressed genes. d (Top) ChIA-PET reveals that a P300 SE loops ~100 kb to physically associate with the promoter
(marked by H3K4me3) of the ESC-specific L1td1 gene. (Bottom) Chromatin interaction between a SE and a gene highly expressed in mESCs,
Epha2. ChIA-PET data are from [20] and depicted as grey lines with blue ends. e In mESCs, 315 additional SEs were identified from P300 density
than from Med1 density. Igf2bp1 is shown as an example of a P300-specific SE (upper panel). In contrast, there are only 29 SEs identified by Med1
in mESCs but not by P300. For example, a Med1-specific SE near the gene Macf1 is shown (bottom panel). There are two SEs in close vicinity to
Macf1; both were identified as SEs by Med1, while only one qualified as a SE by P300
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website (http://www.serbase.org). Next, we demonstrate
the power of this resource using T helper cells and mac-
rophages as systems undergoing cell state transitions.
Role of SEs in T helper cell gene expression programs
Th1, Th2 and Th17 cells differentiate from a common
progenitor, naïve CD4+ T helper cells. They are important
in the adaptive immune response and many immune-
related diseases. Lineage specification of T helper cells first
requires cell activation, provided by stimulation of the T
cell antigen receptor and co-stimulatory molecules such
as CD28, as well as cytokine signaling. T helper cells serve
as a well-characterized model system for understanding
cell differentiation [23].
To determine how SEs regulate gene expression pro-
grams during T helper cell differentiation, we inte-
grated ChIP-seq and RNA-seq data from various
studies [17, 24–27] (Additional file 3: Table S2). We
found that 44 % of SEs were shared by all three T
helper cell subsets and 75 % by two or more cell types
(Fig. 2a and Additional file 4: Figure S2A). When we
compared more distantly related cells, less SEs were
shared: only 10 % of SEs were shared between Th17
cells and mESCs, and 27 % were shared between Th17
cells and activated B cells (Fig. 2b).
To see if SEs are associated with cell-specific gene ex-
pression, we divided T helper cell SEs and expressed
genes into seven modules based on cell specificity (see
Additional file 4: Figure S2B for module definitions).
When SEs were compared to expressed genes in a cor-
responding module (for example, Th1 specific SEs
compared to Th1 specific genes), strong enrichment
was seen: Th1 genes were closer to Th1-unique SEs
(p-value ≤ 2e-8, Students t-test). In Th2 cells, Th2
genes were closer to Th2-unique SEs (p-value ≤ 7e-32,
Students t-test), and Th17 genes were closer to Th17-
unique SEs (p-value ≤ 1e-13, Students t-test).
As validation, known signature cytokines and tran-
scription factors were found in this enrichment analysis.
For example, Tbx21 and Ifng, two signature Th1 genes,
are found near SEs that are inactive in Th2 and Th17
cells, while Rorc and Il17a, Th17 signature genes, are
near Th17-unique SEs (Fig. 2a, c). Cd28, Icos, and Ctla4
share expression in Th1, Th2, and Th17 cells, and P300
SEs are seen in all three cell types (Fig. 2c bottom).
Overall, 4,596 of all 13,194 protein-coding genes
expressed in T helper cells were located within 100 kb
of a T helper cell SE (accounting for 1742/1972 T helper
cell SEs). A list of SE-associated genes in T helper cells
is provided in Additional file 5: Table S3.
The transcription factors STAT3, RORγt, IRF4, and
BATF are required to drive the Th17 gene expression
program [25]. To determine whether these transcription
factors control cell fate through SEs, we analyzed RNA-
seq expression data from Th17 cells treated with the
RORγt inhibitors TMP778 and TMP920 [27], and Th17
cells missing key transcription factors [25]. SE-associated
genes from the Th17 modules, such as the autoimmune
susceptibility genes Il23r and Il17a, were strongly down-
regulated as a result of these perturbations, and we
hypothesize that RORγt, STAT3, and possibly IRF4 and
BATF may be important for mediating Th17 SE activity
(Fig. 2d and Additional file 4: Figure S2D-E). Further
analysis of the constituent regions of SEs in Th17 cells in-
dicates that SEs are highly enriched for sites co-bound by
STAT3, BATF, IRF4, c-MAF and RORγt (p-value < 2.2e-
16, Pearson’s Chi-squared test) (Additional file 4: Figure
S2D). STAT3 is capable of recruiting P300 [28] and may
play a direct role in assembly of super-enhanceosomes. In
Th17 cells missing STAT3, for example, there is a greater
decrease in expression of genes associated with SEs than
CEs (Additional file 1: Figure S1E, p-value ≤ 0.02, Students
t-test).
Transcription of non-coding RNAs in relation to SEs
Since non-coding RNAs are emerging as integral com-
ponents of genetic regulatory networks, we explored
their association with SEs in T helper cells. We looked
at miRNAs and lncRNAs, two classes of non-coding
RNA that are known to be cell specific and to be
involved in gene regulation. We divided T cell lncRNAs
and miRNAs into subset-specific modules (see Additional
file 4: Figure S2B for module definitions) and looked at
enrichment for SEs [26, 29] (Fig. 3a, b; list of lncRNAs
and miRNAs in SE modules in Additional file 6: Tables S4
and Additional file 7: Table S5 respectively). Overall,
enrichment was higher than for protein-coding genes,
as 63 % of lncRNAs vs 47 % of protein-coding genes
were enriched for SEs (p-value < 0.026, Pearson’s Chi-
squared test).
We report that three previously described lineage-
specific T cell lncRNAs are in fact transcribed from
lineage-specific SEs. For example, NeST is a lncRNA im-
portant for protection from Salmonella [30] that is tran-
scribed from a SE 3' of Ifng in Th1 cells (Fig. 3c top).
Interestingly, although the NeST SE is moderately
enriched for P300 in Th2 and Th17 cells, it appears to
only be active in Th1 cells. Additionally, there were two
Th2-specific lncRNAs that were associated with Th2 SEs:
lincR-Epas1-3'-AS and lincR-Gata3-3' (Fig. 3a). These
lncRNAs are regulated by STAT6 in Th2 cells [26].
Next we focused on lncRNAs that are directly tran-
scribed from SEs, as SEs were much more likely to have
lncRNA transcription than CEs (8.3 % of SEs vs. 0.9 %
of CEs in Th17 cells, p-value < 2.2e-16, Pearson’s Chi-
squared test) (Fig. 3d). For example, a SE overlapping
Ccr7 has at least three non-coding transcripts arising
from it (Additional file 8: Figure S3A). Notably, two
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regions of the Ccr7 SEs are conserved between mouse
and human (Fig. 3e). The expression of Ccr7 and its
lncRNAs are reduced in the absence of STAT3 and BATF,
TFs that bind throughout this locus, suggesting that they
are directly regulating transcription of this locus. CCR7 is
an important chemokine receptor for T cell lymph-node
homing, and has a role in T cell mediated pathogenesis of
inflammatory disease [31, 32]. It is a possibility that many
of these transcribed regions within SEs represent eRNAs,
however additional datasets such as GRO-seq are neces-
sary in order to validate this.
A microRNA, miR-142, highly expressed in all T
helper cell subsets, is associated with a shared SE
(Fig. 3b). In contrast, miR-155, appears to be regulated
by a conditional Th17-specific SE (Fig. 3b, c), and as
such, miR-155 has a pro-inflammatory role in Th17
cells [33]. The Mir155 locus contains moderate P300
binding in all three T helper cell lineages, despite the
fact that expression of miR-155 is highest in Th17 cells.
However, one peak located 68 kb 5' of miR-155 is
highly enriched in Th17 cells relative to Th1 and Th2
cells, and may be responsible for the cell lineage speci-
ficity of this gene.
Pharmacologic perturbation and genetic variation of SEs
blocks inflammatory response
We analyzed SEs in unstimulated and stimulated mouse
macrophages and explored their relation to inflamma-
tory gene expression (data from [34–36]). Macrophages
activated by TLR4 signaling had a strikingly different
SE profile than unstimulated macrophages. In all, only
26 % (67/253) of SEs were shared between the two
macrophage states (Fig. 4a). Genes that increase expres-
sion following TLR4 stimulation were closer to an in-
duced SE than pre-existing SEs (p-value ≤ 0.005,
Students t-test) or no SE (p-value ≤ 0.01, Students t-
test) (Additional file 9: Figure S4A). The top 25 most
highly induced or repressed SEs in activated macro-
phages were examined further (Fig. 4b).
Among the top 25 most highly induced SEs, most
were located in the vicinity of genes that are strongly
expressed after macrophage activation (Fig. 4b, top
panel). Many of these genes are known to be essential
players in the macrophage inflammatory response, such
as Il1a, Il1b, Ccl3 and Ccl5 [37, 38]. The most highly ac-
tivated SE is near Rsad2, a gene encoding Viperin, an
antiviral protein that is induced in primary human mac-
rophages [39].
In contrast, many genes which maintain the naïve
macrophage state are located near repressed SEs, and
are expressed at lower levels following macrophage
stimulation (Fig. 4b). For example, SLC29A3, SETDB1,
and TNFAIP8L2 all serve to negatively regulate macro-
phages [40–43]. These findings provide further insight
into the gene expression program that controls macro-
phage homeostasis.
Inhibitors of Brd4 slows tumor cell growth by block-
ing SE-mediated activation of cancer driver genes [3].
To determine whether the inflammatory response can
be attenuated through inhibition of SEs in a similar
manner, we looked at TLR4-stimulated macrophages
that were exposed to the Brd4 inhibitor, iBET. SE-
associated gene expression decreased in macrophages
upon exposure to iBET (Fig. 4c, Additional file 9:
Figure S4B). These findings provide further under-
standing as to why such a drug can confer protection
against systemic inflammation [44].
SEs induced by TLR4 stimulation in macrophages ini-
tially exhibit weak P300 binding in resting macro-
phages, suggesting that many SEs originate at low
density in unstimulated cells (Fig. 4b; examples of this
at Pim1, Gbp gene cluster, Cxcl10 and Mir155 loci in
Fig. 4d, Additional file 9: Figure S4C and S4D). eRNA
expression coinciding with P300 peaks can also be seen
at SEs in some of these examples (Fig. 4d, Additional
file 9: Figure S4D). GBP proteins are critical in host
defense and can activate the inflammasome [45–48].
We found that non-coding expression quantitative trait
loci (eQTL) identified by Fairfax et al. [49], are often
(See figure on previous page.)
Fig. 2 Super-enhancers in T helper cells. a Ternary plot of P300 density at SEs in Th1, Th2, and Th17 cells (left) or gene expression in the same
cells (right). Each dot is a SE or gene. T helper cell SEs are largely shared between all three subsets. Axes indicate relative factor density between
Th1, Th2, and Th17 cells. Color scale indicates concentration of SEs (note: area of graph occupied by color scale for gene expression is much
smaller than area of color scale for P300 density, and is not visible because it is covered by overlapping points). ChIP-seq data are from [24, 25].
RNA-seq data are from [26]. b Ternary plot of P300 density at SEs in mESC, stimulated B cells, and Th17 cells. Color scale indicates concentration
of SEs. Some SEs are shared between B cells and Th17 cells, but are distinct from mESCs, a distantly related cell lineage. B cell ChIP-seq data are
from [74]. c (Top) Il17a and Il17f are regulated by a Th17-specific SE spanning both genes. Also, a non-coding RNA is transcribed 3' of Il17f.
(Bottom) Cd28, Ctla4 and Icos are regulated by two SEs active in Th1, Th2, and Th17 cells. Similar levels of expression and P300 density are seen in
all three cell types. d Genes from both the Th17 SE module and the Th17 gene expression module which have lower expression when treated
with the RORγt inhibiting drugs, TMP778 or TMP920. They are also expressed lower in RORγt-deficient Th17 cells. CE-genes from Th17 cells are
generally unaffected (SE examples were chosen because of known disease relevance, CE examples shown were chosen arbitrarily). Data are
from [27]
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located within a monocyte SE (Fig. 4e, Additional file 9:
Figure S4D-E), providing human genetic evidence for SE-
mediated regulation. eQTLs are nearly twice as enriched
in SEs, compared to CEs (54 % of SEs vs. 29 % of CEs)
(Fig. 4f), although it remains a possibility that this enrich-
ment is due to the fact that both SEs and eQTLs are
enriched near promoters. As an example, we identify a SE
that is associated with SGK1, which encodes a salt-sensing
kinase recently implicated in Th17 development (Fig. 4e)
[50]. The role of SGK1 in macrophages is not fully
understood, although it has been implicated in disease
[51]. Additional examples include NOTCH1 and LITAF,
which also perform important functions in macrophages
(Additional file 9: Figures S4E and S4F).
Discussion
By showing that P300 is a useful marker of SEs in di-
verse cell types, we have established a widely applic-
able approach for prioritizing functionally important
genomic regulatory regions. We provide evidence that
P300 SEs are generally similar to Med1 SEs in
mESCs. The SEs we identified will be useful for un-
derstanding the regulation of genes important for de-
fining cellular identity, which we demonstrate in our
Concentration
High
Low
A B
D
10
0
80
60
40
20
100
80 60 40 20
100
80
60
40
20
Th2
Th1 Th17
Th
2
Th17
10
0
80
60
40
20
100
80 60 40 20
100
80
60
40
20
Th2
Th1 Th17
Th
2
Th17
T Helper Cell LncRNA Expression T Helper Cell miRNA Expression
NeST lncRNAIfng
Th1 SE Th1 SE
100kb
Th1 
Th2 
Th17 
Th1 
Th2 
Th17 
C
Th1 Th2 Th17
Enhancers Near T Helper Cell 
lncRNAs
P
ro
po
rt
io
n 
of
 E
nh
an
ce
rs
0.00
0.05
0.10
0.15
Th1 Th2 Th17
lncRNAs Transcribed 
from Enhancers
P
ro
po
rt
io
n 
of
 E
nh
an
ce
rs
0.00
0.02
0.04
0.06
0.08
SE
CE
Concentration
High
Low
NeST
seRNA
lincR-Epas1-3´-AS
seRNA
LincR-Gata3-3´
seRNA
miR-155
miR-142
Th1 
Th2 
Th17 
Th1 
Th2 
Th17 
R
N
A
-s
eq
P
30
0
R
N
A
-s
eq
P
30
0
Th1, Th2,
Th17 SE
Th1, Th17 
SE Th17 SE
Th1, Th17 
SE
Th1, Th2,
Th17 SE
miR-155
50kb
8810-
8810-
8810-
0.01-
0.01-
0.01-
3467-
3467-
3467-
1.125-
1.125-
1.125-
mm9
mm9
Fig. 3 Non-coding RNAs are frequently near or overlapping SEs. a Ternary plot of lncRNA expression in Th1, Th2, and Th17 cells. Color scale
indicates concentration of lncRNAs. Notable examples of lncRNAs that are lineage specific and located near SEs are shown. RNA-seq data are from
[26]. b Ternary plot of miRNA expression in Th1, Th2, and Th17 cells. Color scale indicates concentration of miRNAs. MiR-155 and miR-142 are
labeled as examples of miRNAs located near SEs. Small RNA-seq data are from [29]. c LncRNAs expressed from SEs are cell-type specific. (Upper
panel) NeST, a lncRNA (or eRNA) that is expressed from the SE at the Ifng locus. NeST, Ifng, and the SE are active in Th1 cells, but not in Th2 or
Th17 cells. (Bottom pane) miR-155 is expressed in Th17 cells and is located near multiple SEs that are active in T helper cells. d A SE is more likely
than a CE to be associated with a lncRNA. Proportion of SEs or CEs that are located within 100 kb of a lncRNA expressed in Th1, Th2, or Th17 cells
(left). Proportion of lncRNAs (or eRNAs) that are directly transcribed from SEs or CEs, in Th1, Th2, and Th17 cells (right) (p-value < 2.2e-16 for all
three comparisons)
Witte et al. BMC Genomics  (2015) 16:903 Page 7 of 13
ALog2 LPS treated macrophage P300 density
Lo
g2
 u
nt
re
at
ed
 m
ac
ro
ph
ag
e 
P
30
0 
de
ns
ity
91 SEs
(LPS treated)
C
E
0.0
0.2
0.4
0.6
0.8
1.0
0
20
40
60
80
R
ec
om
bi
na
tio
n 
R
at
e 
(c
M
/M
b)
R
-S
qu
ar
ed
134270 134520 134770 135020 135270
SGK1
SLC2A12
TBPL1
Chromosome 6 position (hg18) (kb)
CD14+ SE
rs12181791 (CEU)
95 SEs
(untreated macrophages)
67 SEs
(shared)
9.4kb eQTL LD region
Untreated 
LPS 
0
50
00
10
00
0
15
00
0
20
00
0
25
00
0
30
00
0
35
00
0 Inducible genes located
within 100kb of SEs
Density of P300 at SE loci before
and after LPS treatment
B
Socs1 (78x)
Cxcl11 (3525x), Cxcl10 (292x), Cxcl9 (741x)
Lipg (715x)
Gbp3 (52x), Gbp7 (18x), Gbp5 (278x), Gbp2 (142x)
Ccl4 (16x)
Mx2 (51x)
Ccrl2 (53x)
Trex1 (8x)
Csrnp1 (55x)
Il27 (145x), Nupr1 (12x), Ccdc101 (5x)
Il1a (454x), Il1b (329x)
Prdx5 (10x)
Pim1 (8x)
Ccl5 (554x), Gm11435 (517x), Ccl3 (8x)
Rsad2 (132x), Cmpk2 (105x)
-
-
-
-
-
-
-
-
Mir-155 (548x)
-
Mir155 Irg1 Il27 Fpr2 Ccl12
Chemical Inhibitors Disrupt
 Expression of SE Genes
SE Genes
R
el
at
iv
e 
E
xp
re
ss
io
n 
C
ha
ng
e
0
10
0
30
0
50
0
Unstimulated Expression
TLR4 Stimulated Expression
iBET Treatment
0.
0
0.
5
1.
0
Hprt
0
2
0
0
0
4
0
0
0
6
0
0
0
8
0
0
0
1
0
0
0
0
1
2
0
0
0
Untreated 
LPS 
Helb (2.97x)
Cpox (3.63x)
Gm4262 (2.73x), Snx29 (1.47x)
Hs1bp3 (2.28x)
Dhrs3 (9.92x)
Irf2bp2 (2.08x)
Psap (2.77x), Slc29a3 (1.58x)
Ctss (2.39x), Setdb1 (3.23x), Tnfaip8l2 (5.2x)*
Hip1 (5.34x), Tbl2 (4.44x), Wbscr27 (6.59x)
Svil (1.39x)
Galns (2.95x), Mvd (2.27x), Rnf166 (2.79x)
Ccdc48 (1.44x), Prokr1 (8x)
Dgkz (2.57x), Harbi1 (2.14x), Mdk (5.03x)
Gata5 (2.32x), Osbpl2 (5.98x), Slc17a9 (3.12x)
Repressed genes located
within 100kb of SEs
Density of P300 at SE loci before
and after LPS treatment
Sgk1
SE
100kb
eQTL LD Region
CD14+ RNA-seq
H3K27ac
D
-
-
-
-
-
-
-
-
-
-
-
LPS activated SE
Untreated 
TLR4 stimulated
Untreated 
TLR4 stimulated
10kb
G
R
O
-s
eq
P
30
0
F
SE CE
1.0
0.5
0.0
25-
25-
7473-
7473-
mm9
400-
5424-
hg19
Fig. 4 (See legend on next page.)
Witte et al. BMC Genomics  (2015) 16:903 Page 8 of 13
analysis of SEs and gene regulation in multiple cell
state transitions. We report that during macrophage
activation, the SE landscape is substantially remod-
eled, an observation that was not appreciated in pre-
vious studies [8, 9].
By showing that there are differences in the SE reper-
toire between resting and activated macrophage cells,
we suggest that inhibiting these elements could be a
useful strategy to curb inflammation in disease pro-
cesses such as obesity-induced insulin resistance [52].
Specifically, genes regulated by SEs can be selectively
repressed by Brd4 inhibitory drugs, such as iBET, with
little effect on expression of other genes [3]. Genes that
are induced by TLR4 signaling and associated with SEs
in macrophages were strongly repressed by iBET. Since
iBET and similar drugs are currently being clinically evalu-
ated as anti-inflammatory and anti-cancer therapeutics,
understanding their genetic targets in this way could lead
to a better understanding of their mechanisms of action
and possible side effects. In light of our findings, it would
also be interesting to test P300-specific small molecule in-
hibitors [53].
SEs have been proposed to regulate genes important
for cell identity. By examining P300 SEs in several im-
mune cells and ESCs, we show that a large number of
SEs are shared between closely related cells. However,
genes important for cell identity, such as master regula-
tor TFs, are often located near cell-specific SEs. These
results are consistent with the notion that cell-specific
SEs may play an important role in fate decision by regu-
lating key genes, and could represent a novel approach
for reprogramming cell fates. Interestingly, the BET in-
hibitor JQ1 has been demonstrated to inhibit Th17 cells
in mouse and human [54]. Our work suggests that its
mechanism of action may be to perturb SEs in Th17
cells. The findings in macrophages and Th17 cells suggest
that BET inhibitors should be useful in curbing inflamma-
tion and autoimmunity. However, it has also been
proposed to treat cancer, and it is important to monitor
that those patients do not become immunodeficient.
Another acetyltransferase, CBP, a closely related para-
log of P300, may mark a SE repertoire that is nearly
identical to SEs found using P300. Often, P300 and CBP
are considered synonymous and redundant [55, 56].
Due to the similarity between these proteins, the anti-
body used to detect P300 may also bind to CBP, and
vice versa, a possibility that must be considered when
interpreting our results. In humans, heterozygous in-
activating mutation of CBP results in Rubinstein-Taybi
Syndrome [57]. It would be interesting to determine
whether pathogenesis of this disease is related to dis-
ruption of SEs. In addition, there is the P300/CBP-asso-
ciated factor (PCAF) and its paralog, general control of
amino acid synthesis nonrepressed protein 5 (GCN5),
both lysine acetyltransferases. Their roles in relation to
SEs are unknown.
It has been shown that transcription activity at
enhancers is important for neighboring gene expression
[58]. Several lncRNAs that were found to be needed for
the maintenance of pluripotency in a recent screen
[59], are identified here as associated with SEs. Simi-
larly, the lncRNA NeST, which promotes Ifng expres-
sion and the CD8+ T cell response to infection by
Salmonella [60], could be classified as a SE-associated
lncRNA or eRNA. We found that SEs are widely tran-
scribed relative to CEs, sometimes producing multiple
distinct non-coding transcripts (although it does re-
main a possibility SEs are more likely than CEs to be
active, which could also explain this observation). It is
possible that many of these transcripts may be enhan-
cer RNAs (eRNA), which may aid in enhancer regula-
tion of nearby genes [61]. We propose that eRNAs
emanating from SEs should be categorized as seRNAs.
If these seRNAs contribute to SE function, they could
represent an additional avenue for manipulating SE activ-
ity. Further, disease-associated genetic variation at SE sites
(See figure on previous page.)
Fig. 4 Super-enhancers in unstimulated and activated macrophages. a A scatterplot of P300 density at enhancer sites in resting versus stimulated
macrophages. b The density of P300 at many enhancers and SEs is dynamically changed upon stimulation of macrophages. ChIP-seq data are
from [36]. Analysis of top 25 most highly induced SEs upon macrophage activation (top) or repressed SEs (bottom). Density of P300 in activated
macrophages is shown compared to resting macrophages. For those SEs located within 100 kb of a macrophage inducible gene, the name of
the gene(s) is shown along with the fold change in expression (Top: increase in fold change, bottom: decrease in fold change). The absence of a
gene name denotes the absence of an annotated protein-coding gene within 100 kb of the SE. RNA-seq data are from [34]. *continued from
figure due to lack of space: Fam63a (4.38x), Golph3l (2.19x), Lysmd1 (4.92x), Prune (5.89x), Scnm1 (2.13x), Vps45 (2.46x), Tmod4 (4.26x). c The
expression of many genes from (B) is blocked when TLR4-stimulated macrophages are treated with iBET. GRO-seq data are from [35]. d A SE near
Pim1 is induced following TLR4 stimulation. GRO-seq reveals that this SE is also transcribed when active. e (Top) Shown is a local association plot
for a cis-eQTL that regulates the SGK1 gene. The most significantly associated SNP from the linkage disequilibrium (LD) region is rs1281791.
Dotted line designates the R-squared value of 0.8 used as a cutoff for determining linked SNPs. Blue line indicates genomic recombination rate
(y-axis on right). The entire LD region is also located within a SE active in human CD14+ monocytes. eQTL data are from naïve CD14+ cells [49].
(Bottom) Expression of SGK1 in human CD14+ monocytes, along with H3K27ac density (data from GSE18927). f Enrichment of human monocyte
eQTLs in SEs vs. CEs. 550/1019 monocyte SEs overlapped a naïve monocyte eQTL LD region (54 %), compared to only 5471/19028 CEs (29 %).
eQTL data are from [49]
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could lead to disease by disrupting non-coding RNA
and/or SE function.
Conclusions
P300 ChIP-seq data can be leveraged to produce catalogs
of SEs in diverse cell types and provide a useful resource
to reveal key nodes in genetic regulatory networks that
govern cell fate determination. Our findings illustrate the
effectiveness of analyzing and integrating diverse datasets
to make novel insights into biological processes, and our
curated SEs will serve as an important resource to the sci-
entific community.
Methods
ChIP-Seq analysis
All data sets used in this project are listed in Additional file
2: Tables S1 and Additional file 3: Table S2. ChIP-seq reads
were mapped to either the mm9 build or hg19 build for
mouse and human, respectively, using Bowtie (0.12.7) [62]
and the following parameters: −m 2, −n 2, −k 1, −-best.
Peaks for transcription factors and histone modifications
were found using MACS (version 1.4.1) with the op-
tions –B, −n, −p 1e-9, −-keep-dup = auto [63]. Input
control datasets and replicates were utilized whenever
available (see Additional file 3: Table S2).
Defining enhancers and super-enhancers
Enhancers and SEs were determined using a previously
established approach [1]. Briefly, P300 ChIP-seq peaks
with a p-value ≤ 1e-9 located within 12,500 base pairs
from each other were stitched together to define en-
hancers as previously described for Med1 (with the only
exception of mESC analysis in Fig. 1 that were per-
formed using previously reported mouse enhancer sites
[1]). Peaks located within 2,000 bp of a transcription
start site were excluded. The ROSE algorithm [4] was
used to calculate factor density within each enhancer,
subtract input background, and rank enhancer regions
via normalized read count. Enhancers were plotted with
enhancer rank versus enhancer density, and all enhancer
regions above the inflection point of the curve were de-
fined as SEs.
RNA-seq and GRO-seq analysis
RNA-seq reads were mapped to the mm9 genome using
Tophat (version 2.011) [64]. Transcript abundances were
estimated using HTSeq (version 0.6.1) [65]. Differential
expression was calculated using DESeq (version 2.14) [66].
Coding gene, LncRNA, miRNA, promoter, and eQTL
overlap with enhancers
Genome coordinates of enhancer loci extended by 100 kb
were compared to genome coordinates of protein coding,
lncRNA and miRNA genes, as well as eQTLs. Any
transcriptional elements that overlapped SEs by 1 bp or
more were assigned to that SE. Gene coordinates were ob-
tained from Ensembl release 65. lncRNA coordinates are
from [26], miRNA coordinates are from miRBase 19. mESC
promoters were defined by identifying H3K4me3 ChIP-seq
peaks in mESCs and filtering for those which overlap any
transcription start sites. All ternary plots were generated
using the R package ggtern (version 1.0.3.2). The linkage
disequilibrium (LD) region was calculated for each eQTL
SNP using PLINK 1.9 [67] against the European individuals
from the 1000 genomes reference panel [68].
Genome browser screenshots
ChIP-seq and RNA-seq files were converted to the big-
wig format, then uploaded as custom tracks to the
UCSC genome browser [69]. Screenshots were down-
loaded and annotated in Adobe Illustrator. All scale bars
for RNA-seq and ChIP-seq tracks contain 0 as the base-
line (only the top scale bar is shown for each track to
save space). Units are in tags per million, with the excep-
tion of the RNA-seq tracks in Fig. 2c, d, Fig. 3c, and e,
which are in units of tags per total mapped reads. The
plot and LD region for SNP rs12181791, rs7849014 and
rs12446552 was calculated using the SNP Annotation
and Proxy Search tool [70].
Availability of supporting data
The datasets supporting the results of this article are in-
cluded in Additional file 3: Table S2.
Additional files
Additional file 1: Figure S1. A. All loci that were identified as SEs using
both Med1 and P300 were compared by factor density. The correlation
coefficient was determined to be 0.89. B. Average distance between
enhancer regions and transcription start sites (TSS) for mESCs and other cells
types. C. Average size of SEs. SEs were identified in mESCs using Med1, P300,
and H3K27Ac ChIP-seq data. The average length in bp of each SE was calcu-
lated. ChIP-seq data are from [71, 72]. D. Example of a P300 SE in Sox2 locus,
a pluripotency gene, conserved between mouse and human ESCs. E. P300
SEs interacts physically with promoters in mESCs. Promoters were defined as
H3K4me3 peaks that overlapped a transcription start site. Interactions
between SEs and promoters were seen for 149 genes via Cohesin ChIA-PET,
and 167 genes via RNA polymerase II ChIA-PET. 58 of these interactions were
reproduced between both datasets. H3K4me3 data are from [1], Cohesin
ChIA-PET is from [18], and RNA polymerase II ChIA-PET is from [20]. F. CBP
marks a very similar SE repertoire as P300. SEs were determined from both
P300 and CBP datasets in human T98 cells; 629/636 CBP SEs (98.9 %) were
also identified from P300 data. Data are from [73]. (DOC 233 kb)
Additional file 2: Table S1. Publicly available datasets used to curate
SE catalogs.(XLSX 51 kb)
Additional file 3: Table S2. A summary of datasets used in this
study.(XLSX 14 kb)
Additional file 4: Figure S2. A. SEs for Th1, Th2, and Th17 cells (from
Fig. 3a) were grouped into modules based on module definitions in B. A
Venn diagram was created based on these modules, depicting SEs that are
either specific to a single type of cell or shared between two or three cell
types. Data are from [26]. B. Cell specific modules. Genes, lncRNAs, miRNAs,
and SEs were plotted based on relative expression (measured by RNA-seq, or
ChIP-seq factor density for SEs calculated using the ROSE algorithm [1])
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between three types of cells using the R package ggtern. Cell specific
elements were defined as those with at least 60 % of expression or factor
density in a single cell type (purple, red, and green areas). Elements shared
between 2 or 3 types of cells were assigned to modules in a similar manner
(see figure). C. Genes from both Th17 SE module and Th17 gene expression
module have lower expression when missing the transcription factors Stat3,
Irf4, and C-maf. CE-genes shown are unaffected. Data are from [25, 26]. D. The
number constituent P300 peaks from Th17 SEs and TEs that overlap genomic
regions containing all of the transcription factors STAT3, IRF4, BATF, c-MAF,
and RORγt. Of 8,249 total genomic regions containing all 5 factors, 91 did not
overlap either SEs or CEs. Data are from [25]. E. Comparison of Th17 specific
genes that are associated with Th17 specific SEs or CEs reveals that SE
associated genes are significantly more dependent on Stat3 for expression
perturbation (p-value≤ 0.019, one-tailed students t-test). Th17 specific genes
located within 100 kb of a Th17 specific SE represent the ‘SE-associated
Genes.’ Th17 specific genes within 100 kb of a CE represent the ‘CE-associated
Genes.’ Data are from [25, 26]. (DOC 247 kb)
Additional file 5: Table S3. Cell-specific SE-associated genes in T helper
cells.(XLSX 74 kb)
Additional file 6: Table S4. Cell-specific SE-associated lncRNAs in T
helper cells.(XLSX 58 kb)
Additional file 7: Table S5. Table S5: Cell-specific SE-associated miRNAs
in T helper cells.(XLSX 35 kb)
Additional file 8: Figure S3. A. A genome browser screenshot depicts
a mouse SE which overlaps the Ccr7 gene and lncRNAs (or eRNAs) that
are enriched in Th17 cells. Expression of these lncRNAs in Th17 cells
depend on Stat3 or Batf, and these two transcription factors bind
extensively throughout this locus and co-localize with P300. This locus
also contains sequence homology to two human Th17 cell-specific SEs
[4], mapped by synteny. Data are from [25]. (DOC 100 kb)
Additional file 9: Figure S4. A. All expressed genes in macrophages were
assigned to either TLR4 induced SEs, pre-existing SEs, or no SE association.
Fold change in expression following TLR4 stimulation was analyzed for these
three groups of genes. B. iBET decreases the expression of SE associated
genes in TLR4 stimulated macrophages. The genes located within 100 kb of
the top 25 most highly induced SEs (following TLR4 stimulation) show a
smaller increase in expression when treated with iBET (p-value = 0.001,
Students t test). Gene expression fold changes were log2 transformed prior
to plotting. C. A CE with low P300 density in resting macrophages becomes
a SE in activated macrophages. There is also corresponding activation of
expression of the genes Gbp5, Gbp7, Gbp3, and Gbp2 that can be inhibited by
iBET. D. (Top) An enhancer with low P300 density in resting macrophages
becomes a SE in activated macrophages. There is a 292x fold increase in the
expression of the nearby gene Cxcl10 when the enhancer becomes an active
SE. Data are from [36] and [34]. (Bottom) Two SEs near the Mir155 are induced
in activated macrophages. There is a 548x fold increase in the expression of
Mir155 primary transcript. E. (Top) Shown is a local association plot for a
cis-eQTL that regulates the NOTCH1 gene. The most significantly associated
SNP from the linkage disequilibrium (LD) region is rs7849014. The majority of
the LD region is also located within a CD14+ SE. eQTL data are from naïve
CD14+ cells [49]. (Bottom) Expression of NOTCH1 in CD14+ cells, along
with H3K27ac density (data are from GSE18927). F. (Top) Shown is a local
association plot for a cis-eQTL that regulates the LITAF gene. The most
significantly associated SNP from the linkage disequilibrium (LD) region is
rs12446552. The majority of the LD region is also located within a CD14+
SE that we identified. eQTL data are from naïve CD14+ cells [49].
(Bottom) Expression of LITAF in CD14+ cells, along with H3K27ac density
(data from GSE18927). (PDF 105 kb)
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